Mitsuteru Hiwatari

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Cancer gene therapy

Blood advances

Pediatric blood & cancer

Oncogene

Tokyo Daigaku

Tokyo Daigaku (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tokyo Daigaku Aug 01 2015

Japan

Lecturer :: Cell Therapy and Transplant Medicine

Education History

Tokyo Daigaku Apr 01 2001 - Mar 24 2005

Japan

PHD

Publications

Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer gene therapy 31 (7) (2024)
Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer gene therapy 31 (7) (2024)
Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer gene therapy 31 (7) (2024)
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, Nobuyuki Kakiuchi, Yasuhito Nannya, Seishi Ogawa, Hidefumi Hiramatsu, Junko Takita
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood advances 8 (5) (2024)
Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer gene therapy 31 (7) (2024)
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, Nobuyuki Kakiuchi, Yasuhito Nannya, Seishi Ogawa, Hidefumi Hiramatsu, Junko Takita
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood advances 8 (5) (2024)
Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Tetsuo Ushiku, Motohiro Kato, Akira Oka, Satoru Miyano, Seishi Ogawa, Junko Takita
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer gene therapy (2024)
Nao Takasugi, Kaname Uchida, Konomi Shimoda, Eiichiro Watanabe, Shota Kato, Mitsuteru Hiwatari, Mahoko Ikeda, Motohiro Kato, Hikoro Matsui
Management of fulminant botulism after allogeneic hematopoietic cell transplantation. Pediatric blood & cancer (2024)
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, Nobuyuki Kakiuchi, Yasuhito Nannya, Seishi Ogawa, Hidefumi Hiramatsu, Junko Takita
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood advances (2023)
Mitsuteru Hiwatari, Masafumi Seki, Ryosuke Matsuno, Kenichi Yoshida, Takeshi Nagasawa, Aiko Sato-Otsubo, Shohei Yamamoto, Motohiro Kato, Kentaro Watanabe, Masahiro Sekiguchi, Satoru Miyano, Seishi Ogawa, Junko Takita
Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma. Oncogene 41 (20) (2022)
Hisashi Ishida, Motohiro Kato, Yuta Kawahara, Sae Ishimaru, Yuho Najima, Shinichi Kako, Maho Sato, Mitsuteru Hiwatari, Maiko Noguchi, Keisuke Kato, Katsuyoshi Koh, Keiko Okada, Fuminori Iwasaki, Ryoji Kobayashi, Shunji Igarashi, Shoji Saito, Yoshiyuki Takahashi, Atsushi Sato, Junji Tanaka, Yoshiko Hashii, Yoshiko Atsuta, Hirotoshi Sakaguchi, Toshihiko Imamura
Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation. Hematological oncology 40 (3) (2022)
Shota Kato, Yoshiko Nakano, Yuki Nakano, Koh Okamoto, Nao Takasugi, Moe Hidaka, Masahiro Sekiguchi, Mitsuteru Hiwatari, Makoto Kurano, Motohiro Kato
COVID-19 in an adolescent with aplastic anemia undergoing immunosuppressive therapy: A case report and details of antibody testing for SARS-CoV-2. Pediatric blood & cancer (2021)
Shota Kato, Yasuo Kubota, Kentaro Watanabe, Keita Hogetsu, Yuki Arakawa, Katsuyoshi Koh, Junko Takita, Mitsuteru Hiwatari
Tandem high-dose chemotherapy with autologous stem cell rescue for stage M high-risk neuroblastoma: Experience using melphalan/etoposide/carboplatin and busulfan/melphalan regimens. Pediatric transplantation 24 (7) (2020)
Shota Kato, Yasuo Kubota, Masahiro Sekiguchi, Kentaro Watanabe, Aya Shinozaki-Ushiku, Junko Takita, Mitsuteru Hiwatari
KMT2A-rearranged diffuse large B-cell lymphoma in a child: a case report and molecular characterization. Pediatric hematology and oncology 38 (3) (2020)
Kenichi Amano, Nao Takasugi, Yasuo Kubota, Yuichi Mitani, Masahiro Sekiguchi, Kentaro Watanabe, Junya Fujimura, Akira Oka, Junko Takita, Mitsuteru Hiwatari
CBFA2T3-GLIS2-positive acute megakaryoblastic leukemia in a patient with Down syndrome. Pediatric blood & cancer 67 (2) (2019)
Yuichi Mitani, Mitsuteru Hiwatari, Masafumi Seki, Mayumi Hangai, Junko Takita
Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions. International journal of hematology 110 (4) (2019)

Mitsuteru Hiwatari.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mitsuteru Hiwatari